The U.S. obesity rate continues to rise, with approximately 40% of adults over the age of 20 now classified as obese—an increase of 10 percentage points over the past two decades. Obesity significantly raises the risk of chronic diseases such as type 2 diabetes, and poor dietary habits are linked to over 300,000 deaths annually in the United States.
Food choices are a key determinant of health. Researchers at the Fralin Biomedical Research Institute at Virginia Tech are investigating how obesity affects neural circuits in the brain related to reward, motivation, and emotion. Their work aims to bridge the gap between animal and human studies by exploring the link between the brain's food reward system and metabolic diseases.
While past studies have relied heavily on animal models, recent technological advances now allow scientists to monitor chemical signals in the human brain in real time. The research team is using innovative electrochemical techniques to collect brain data from epilepsy patients with implanted electrodes. During the experiment, participants consumed sugary drinks via a custom pump system and completed language tasks related to food and emotion, while researchers measured brain activity tied to reward processing.
Findings suggest that the brain encodes simple stimuli like sweetness differently from complex stimuli such as language. Notably, all current weight-loss medications target brain reward regions, yet evidence indicates that these areas may not fully revert to their pre-obesity state even after significant weight loss. This insight may prove critical for developing more effective long-term interventions.